Outcomes from latest research reveal that the polarization course of will increase COX 2 Inhibition by 572%
LOS ANGELES, July 2, 2019 /PRNewswire/ -- Quanta, Inc. (QNTA), an applied science company focused on enhancing energy levels in plant matter, including hemp and cannabis, to increase performance within the human body, announced today that they released a new white paper " CBD in the Quantum Era - Polarization and its effects on anti-inflammatory abilities of cannabidiol ( CBD)" which shows that Quanta's patented polarization technology increases the effectiveness of CBD to inhibit the COX 2 enzyme by 572%. In other words, the polarization process greatly increases the ability of CBD to reduce inflammation." data-reactid="12">LOS ANGELES, July 2, 2019 /PRNewswire/ — Quanta, Inc. (QNTA), an utilized science firm targeted on enhancing power ranges in plant matter, together with hemp and cannabis, to extend efficiency throughout the human physique, introduced right now that they launched a brand new white paper “ CBD within the Quantum Period – Polarization and its results on anti-inflammatory skills of cannabidiol ( CBD)” which exhibits that Quanta’s patented polarization know-how will increase the effectiveness of CBD to inhibit the COX 2 enzyme by 572%. In different phrases, the polarization course of vastly will increase the flexibility of CBD to cut back irritation.
Quanta’s proprietary know-how makes use of quantum mechanics to extend the bio-activity of focused molecules which boosts the specified impact. The polarization know-how is utilized to many substances, together with CBD, to govern and stabilize electron spin in naturally occurring components to extend efficiency within the physique. The Firm mission is to create pure, sustainable therapeutic options which are as highly effective and predictable as pharmaceutical medication.
The corporate not too long ago carried out a petri dish research introducing conventional CBD and a pair of ranges of Polarized CBD to the COX 2 enzyme, which is accountable for irritation ache and fever. The next key outcomes emerged from the report and are detailed within the white paper:
- Conventional CBD confirmed a 12% fee of COX 2 inhibition
- Medium Depth Polarized CBD confirmed a 46% fee of COX 2 inhibition
- Excessive Depth Polarized CBD confirmed a 71% fee of COX 2 inhibition
Eric Rice. "A 572% increase in the effectiveness of CBD as a COX 2 inhibitor is encouraging, considering the importance it will play in the lives of millions of people around the world and the escalating demand for CBD products in today's marketplace. We released the white paper to show the capabilities of our technology as we strive to establish ourselves as a leader within the anti-inflammatory and commercial CBD industries."" data-reactid="19">“We’re more than happy and humbled with the outcomes of this research,” mentioned Quanta, Inc.’s Chief Government Officer, Mr. Eric Rice. “A 572% enhance within the effectiveness of CBD as a COX 2 inhibitor is encouraging, contemplating the significance it’s going to play within the lives of thousands and thousands of individuals all over the world and the escalating demand for CBD merchandise in right now’s market. We launched the white paper to indicate the capabilities of our know-how as we attempt to determine ourselves as a frontrunner throughout the anti-inflammatory and industrial CBD industries.”
The Brightfield Group (a advertising analysis group specializing within the CBD business) has estimated that the American CBD market will attain a surprising $22 billion by 2022. This knowledge represents a rise, from a latest forecast made by New York-based funding financial institution Cowen & Co, which estimated that the market may pull in $15 billion by 2025.
To view the white paper in full, go to: http://www.quanta9.com/wp-content/uploads/2017/07/Quanta-Revealed-White-Paper.pdf.
Quanta, Inc., an applied science company, focused on enhancing energy levels in plant matter (including cannabis) to increase performance within the human body. Its proprietary technology uses quantum mechanics to increase the bio-activity of targeted molecules to enhance the desired effects. The Company specializes in potentiating rare naturally occurring elements to create impactful and sustainable healing solutions that are as powerful and predictable as pharmaceutical drugs. Quanta offers its technology as a platform to product makers through distribution channels, as well as consumer products. The Company serves brands in cannabis, anti-aging, health and wellness, stress management, pain management, fitness, and brain performance enhancement. Quanta's flagship product is a CBD pain relief rub. This all-natural topical consists of 13 natural elements including turmeric, arnica and polarized cannabidiol ( CBD), designed to provide relief from pain, inflammation, and stiffness in muscles and joints. The Company was founded in 2016 and is headquartered in Los Angeles, California. For more information, please visit http://www.quantacbd.com/ and review Quanta's filings with the U.S. Securities and Exchange Commission." data-reactid="22">About Quanta
Quanta, Inc., an utilized science firm, targeted on enhancing power ranges in plant matter (together with cannabis) to extend efficiency throughout the human physique. Its proprietary know-how makes use of quantum mechanics to extend the bio-activity of focused molecules to boost the specified results. The Firm makes a speciality of potentiating uncommon naturally occurring components to create impactful and sustainable therapeutic options which are as highly effective and predictable as pharmaceutical medication. Quanta gives its know-how as a platform to product makers via distribution channels, in addition to client merchandise. The Firm serves manufacturers in cannabis, anti-aging, well being and wellness, stress administration, ache administration, health, and mind efficiency enhancement. Quanta’s flagship product is a CBD ache reduction rub. This all-natural topical consists of 13 pure components together with turmeric, arnica and polarized cannabidiol ( CBD), designed to supply reduction from ache, irritation, and stiffness in muscle groups and joints. The Firm was based in 2016 and is headquartered in Los Angeles, California. For extra data, please go to http://www.quantacbd.com/ and assessment Quanta’s filings with the U.S. Securities and Alternate Fee.
View authentic content material:http://www.prnewswire.com/news-releases/polarization-technology-increases-cbds-ability-to-reduce-inflammation-by-more-than-500-300879551.html